Emerging Companies - Legal services - Hogan Lovells

Emerging Companies

Creating new products, improving existing concepts and venturing into new markets. Emerging and growth-stage companies face a challenging landscape, but also one that offers the opportunity to disrupt the way we live, work and interact.

  • icon

You have developed an innovative idea into a profitable, fast growth business model. What next? We offer unique guidance for emerging and growth-stage companies to help them navigate through every stage of fundraising to further support their growth and strategy.

Our industry focus across fintech, consumer, tech, life sciences and automotive enables us to identify, and even anticipate regulatory changes, market dynamics, and trends that will redefine the shape of an industry. We leverage this industry insight to help emerging and growth-stage companies shape the future.

We strive to build strategic and valuable connections among investors, entrepreneurs, and companies, with a view to building long term, mutually beneficial relationships. We are proud of our role in helping entrepreneurs turn an idea into a business reality.

Representative experience

March Biosciences, an emerging clinical stage biotechnology company committed to combating challenging cancers and other diseases, in the closing of a US$28.4m oversubscribed Series A financing.
Sanergy, an organic waste upcycling business transforming how emerging markets manufacture agricultural inputs utilizing a circular economy approach, on its Series C capital raise.
Avelios Medical, a Germany-based software company digitalizing hospital workflows and data-driven patient care, on its €30m Series A funding round led by Sequoia Capital.
OncoVerity, a pioneer in applying advanced bioinformatics to drug development, on the closing of a Series A extension financing led by existing investors, argenx and RefinedScience.
The Exploration Company, a Franco-German spacecraft manufacturer, on its US$160m Series B financing round to fund continued development of its Nyx spacecraft, Europe’s first reusable space capsule.
FlixMobility on all financing rounds, including its US$650m Series G, valued at US$3bn.

You may also be interested in...